🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial was designed to assess safety and preliminary efficacy of oral d...
Status
Completed
Location
Pharmaron
Start Date
2019-11-04
Trial ID
NCT04150250
Treatments Being Tested
This study, performed over a course of 3 years in 5 collaborating hospitals...
Status
Completed
Location
Cameroon Baptist Convention Health Services
Start Date
2018-01-12
Trial ID
NCT03248297
Treatments Being Tested
The goal of this trial is to compare the non-inferiority efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT02726269
Treatments Being Tested
Pulmonary infection with Burkholderia cepacia complex (BCC) in patients wit...
Status
Unknown
Location
St. Michael's Hospital
Start Date
2006-02
Trial ID
NCT00298922
Treatments Being Tested
The phase II clinical trial, with three arms and at rate of 10 patients per...
Status
Unknown
Location
Donka; Kenien; Gbessia
Start Date
2020-06-01
Trial ID
NCT04502342
This is an exploratory study to describe the pharmacokinetics of the azithr...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2024-08-08
Trial ID
NCT05796362
Treatments Being Tested
The primary objective of this study is to generate evidence demonstrating t...
Status
Completed
Location
USA008
Start Date
2020-12-22
Trial ID
NCT04677543
Treatments Being Tested
This is a retrospective observational cohort study. About 1000 hospital cha...
Status
Completed
Location
City Clinical Hospital No. 52 of the Department of Health of the City of Moscow
Start Date
2020-02-01
Trial ID
NCT05302947
Treatments Being Tested
The present study is designed for patients with mild COVID-19 phase, to dem...
Status
Completed
Location
Alma Italia Guerrero Martinez
Start Date
2020-12-16
Trial ID
NCT04673214
The primary objective of this phase 2, multicentric, placebo-controlled dou...
Status
Withdrawn
Location
Institut de Cancérologie Strasbourg Europe
Start Date
2020-09-02
Trial ID
NCT04392128